Background: The etiology of prostate cancer (PCa) is not well-known, and the role of diet is not well established. We aimed to evaluate the role of the inflammatory power of the diet, measured by the Dietary Inflammatory Index (DII), on the risk of PCa.

Methodology: A population-based multicase-control (MCC-Spain) study was conducted. Information was collected on sociodemographic characteristics, personal and family antecedents, and lifestyles, including diet from a Food Frequency Questionnaire. The inflammatory potential of the diet was assessed using the energy-adjusted Dietary Inflammatory Index (E-DII) based on 30 parameters (a higher score indicates a higher inflammatory capacity of the diet). Tertiles of E-DII were created using the cut-off points from the control group. The International Society of Urology Pathology (ISUP) was grouped as ISUP 1, ISUP 2, or ISUP 3-5. Unconditional logistic regression models were used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CI) for the association between E-DII score and PCa risk.

Results: A total of 928 PCa cases and 1278 population controls were included. Among PCa cases, the mean value of the E-DII score was 0.18 (SD: 1.9) vs. 0.07 (SD: 1.9) in the control group (p = 0.162). Cases with a more pro-inflammatory diet (3rd tertile) had the highest risk of PCa, aOR= 1.30 (95% CI 1.03-1.65) (p-trend = 0.026). When stratifying by ISUP, this risk association was observed only for ISUP 2 and ISUP 3-5, aOR= 1.46 (95% CI 1.02-2.10) and 1.60 (95% CI 1.10-2.34), respectively.

Conclusion: A positive association was observed between consuming a pro-inflammatory diet and PCa in the MCC-Spain population, specifically for an ISUP grade greater or equal than 2.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41391-022-00532-7DOI Listing

Publication Analysis

Top Keywords

isup isup
12
dietary inflammatory
8
prostate cancer
8
mcc-spain study
8
control group
8
isup
8
isup 3-5
8
pca cases
8
pro-inflammatory diet
8
association observed
8

Similar Publications

Article Synopsis
  • Recent clinical trials indicate that patients with metastatic castration-sensitive prostate cancer exhibit varying overall survival rates based on tumor burden and visceral metastasis, with some low-burden patients still facing poor survival.
  • This study examined data from 261 newly diagnosed patients to assess time to castration resistance as a potential prognostic factor, alongside other variables like age and metastasis type.
  • Results showed that a shorter time to castration resistance significantly correlated with reduced overall survival, highlighting the persistence of androgen receptor signaling even post-castration resistance and suggesting its potential as a biomarker regardless of tumor burden.
View Article and Find Full Text PDF

Objective: To perform a systematic review and meta-analysis to assess the relationship between intraprostatic maximum standardised uptake value (SUV) of the dominant prostatic lesion as measured on preoperative prostate-specific membrane antigen (PSMA) positron emission tomography (PET) with radical prostatectomy International Society of Urological Pathology (ISUP) Grade Group, pathological tumour (pT) staging, and biochemical recurrence (BCR).

Methods: Prostate-specific membrane antigen PET may offer non-invasive assessment of histopathological and oncological outcomes before definitive treatment. SUV of the dominant lesion has been explored as a prognostic biomarker.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to determine if diffuse, bilateral PI-RADS 3 changes on MRI of the prostate indicate clinically significant prostate cancer (csPCa).
  • Data from 108 men with these MRI findings who underwent biopsies were analyzed, and it was found that 30.5% were diagnosed with csPCa.
  • A significant correlation was identified between prostate-specific antigen density (PSAd) and the presence of cancer, suggesting that careful evaluation is needed before dismissing the need for biopsy in these cases.
View Article and Find Full Text PDF

Introduction: A significant proportion of newly diagnosed prostate cancer (PCa) cases are slow growing with a low risk of metastatic progression. There is a lack of data concerning the optimal biopsy regimen for improving diagnosis yield in PI-RADS3 lesions. This study aimed to assess the diagnostic value of current biopsy regimens in PI-RADS 3 lesions and identify clinical predictors to improve clinically significant PCa (csPCa) detection.

View Article and Find Full Text PDF

To investigate the potential association between body mass index (BMI) and the clinicopathological features of patients with clear cell renal cell carcinoma (ccRCC). We retrospectively analyzed data from 2541 patients who underwent partial or radical nephrectomy for renal masses between 2013 and 2023 in a single institution. Patients were divided into normal-weight, overweight, and obese groups based on the Chinese BMI classification.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!